Posters 2024

Theme

Number

Infos

Abstract

Poster

Cirrhosis

P09

Massive Acute Variceal bleed controlled by Transjugular Intrahepatic Porto-Systemic Shunt (TIPSS) with antegrade transvenous obliteration of gastroesopheal varices
R. JAIN, New Delhi, India

Abstract

Cirrhosis

P15

Infection in cirrhotics: Prevalence and impact on prognosis in the hepatogastroenterology department of Aristide Le Dantec hospital
A. FALL, Dakar, Sénégal

Abstract

Poster

Cirrhosis

P23

The Intersection of Rare: Gaucher Disease Complicated by Cirrhosis, Hemochromatosis, and Acute Coronary Syndrome
S. SONLINE, Kozhikode, India

Abstract

HCC

P08

Endothelial autophagy deficiency promotes liver carcinogenesis-related to MASLD
S. LAOUIREM, Paris, France

Abstract

Poster

HCC

P12

Characterization of the intratumoral immune microenvironment of hepatocellular carcinoma before selective intrahepatic radiation therapy and study of its prognostic value on response to treatment
P. VIGNERON, Créteil, France

Abstract

Poster

HCC

P16

Epidemiological, clinical, therapeutic and prognostic features of hepatocellular carcinoma in a sub saharan country
A.W. Ndjitoyap Ndam, Yaounde, Cameroon

Abstract

Poster

HCC

P20

Shear-wave sono-elastography in the discrimination of hepatocellular carcinoma and dysplastic nodules in cirrhotic patients
R. RABABOC, Bucharest, Romania

Abstract

Poster

HCC

P32

FIB-4 in predicting hepatocellular carcinoma during viral hepatitis: A novel indication for an old tool
M. AYARI, Tunis, Tunisia

Abstract

Poster

Hepatitis B

P30

Management of CHB patients outside the guidelines: insights from Egyptian cohort with long-term follow up
G. SHIHA, Egypt

Abstract

Hepatitis C

P02

The value of hyaluronic acid testing in HCV- induced early fibrosis verification
I. BONDARUK, Vinnytsya, Urkraine

Abstract

Poster

Hepatitis C

P06

New monitoring aspects in the achievement of sustained virological response among patients with chronic viral hepatitis C: emphasis on immunological variability
T. BEVZ, Vinnytsya, Ukraine

Abstract

Poster

Hepatitis C

P07

Immunological and biochemical correlation of the main pathogenicity links of chronic viral hepatits C
T. BEVZ, Vinnytsya, Ukraine

Abstract

Hepatitis C

P18

Impact of HCV cure in patients with systemic autoimmune diseases
L. ILIESCU, Bucharest, Romania

Abstract

Poster

MASH

P05

Management of severe acute alcoholic hepatitis in France: results of a national survey
J. F. D. CADRANEL, Creil, France

Abstract

Poster

MASH

P11

Understanding Barriers in Non-Alcoholic Liver Disease (NAFLD) Management: Insights from A Multi-Disciplinary Survey of Physicians in Europe
L. CASTERA, Clichy, France

Abstract

MASH

P13

Results of Nash-FibroTest in Armenian patients with MAFLD
N. SARGSYANTS, Yerevan, Armenia

Abstract

Poster

MASH

P14

A social media listening study of patients’ experiences toward NAFLD (LISTEN-NAFLD)
L. CASTERA, Clichy, France

Abstract

MASH

P19

Weight loss is associated with decreased serum insulin levels in non-diabetic MASH patients
L. TOMA, Bucharest, Romania

Abstract

Poster

MASH

P28

PNPLA3 rs738409 polymorphisms clinical profile in a MAFLD Mexican cohort
A. L. LADRON DE GUEVARA CETINA, Mexico, Mexico

Abstract

Poster

MASH

P29

Prognostic role of ELF test compared to liver biopsy in patients with MASLD
A. LIGUORI, Rome Italy

Abstract

Poster

Other

P03

Insights from the European Liver Patients' Association’s mobile testing at the European Parliament
B. CREDI, Belgium

Abstract

Poster

Other

P04

Translating the Role of Vitamin D Supplementation in Chronic Liver Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
P. MARTINEKOVA

Abstract

Poster

Other

P17

Management of patients admitted for Acute liver failure in a subsaharan country
A.W. Ndjitoyap Ndam, Yaounde, Cameroon

Abstract

Poster

Viral Hepatitis

P31

Fibrosis is not regressed 5 years after HCV and HBV treatment, MAFLD can be the cause
F. ABDEL HAMID, Fayoum, Egypt

Abstract